1. The combination of an inclusive novel agent treatment strategy, pre‐emptive therapy dose reduction, and prolonged therapy results in good outcomes in elderly myeloma patients. (12th March 2019) Authors: Ediriwickrama, Nadishani; Oyebamiji, Titi; Munisamy, Sreetharan; Garland, Paula; Cuthill, Kirsty; Benjamin, Reuben; Ceesay, M. Mansour; Bowcock, Stella Journal: British journal of haematology Issue: Volume 186:Number 3(2019) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma. Issue 3 (17th March 2021) Authors: Shah, Mili; Kuhnl, Andrea; Shields, Gregory; Sudhanva, Malur; Metaxa, Victoria; Wong, Shu; Yallop, Deborah; Patten, Piers; Inam, Shafqat; Hockings, Catherine; Stewart, Orla; Benjamin, Reuben; Cuthill, Kirsty; Pagliuca, Antonio; Potter, Victoria; Sanderson, Robin Journal: HemaSphere Issue: Volume 5:Issue 3(2021) Page Start: e535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre UK experience. (17th February 2017) Authors: Maciocia, Nicola; Melville, Andrew; Cheesman, Simon; Sharpley, Faye; Ramasamy, Karthik; Streetly, Matthew; Jenner, Matthew; Benjamin, Reuben; Schey, Steve; Maciocia, Paul; Popat, Rakesh; D'sa, Shirley; Rismani, Ali; Cerner, Aviva; Yong, Kwee; Rabin, Neil Journal: British journal of haematology Issue: Volume 176:Number 6(2017) Page Start: 908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study. Issue 3 (29th December 2021) Authors: Delimpasi, Sosana; Mateos, Maria Victoria; Auner, Holger W.; Gavriatopoulou, Maria; Dimopoulos, Meletios A.; Quach, Hang; Pylypenko, Halyna; Hájek, Roman; Leleu, Xavier; Dolai, Tuphan Kanti; Sinha, Dinesh Kumar; Venner, Christopher P.; Benjamin, Reuben; Garg, Mamta Krishnan; Doronin, Vadim; Levy,... Journal: American journal of hematology Issue: Volume 97:Issue 3(2022) Page Start: E83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. Issue 6 (3rd May 2021) Authors: Auner, Holger W.; Gavriatopoulou, Maria; Delimpasi, Sosana; Simonova, Maryana; Spicka, Ivan; Pour, Ludek; Dimopoulos, Meletios A.; Kriachok, Iryna; Pylypenko, Halyna; Leleu, Xavier; Doronin, Vadim; Usenko, Ganna; Hajek, Roman; Benjamin, Reuben; Dolai, Tuphan Kanti; Sinha, Dinesh Kumar; Venner, Ch... Journal: American journal of hematology Issue: Volume 96:Issue 6(2021) Page Start: 708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3. (2019) Authors: Tornatore, Laura; Capece, Daria; D'Andrea, Daniel; Begalli, Federica; Verzella, Daniela; Bennett, Jason; Acton, Gary; Campbell, Elizabeth A.; Kelly, James; Tarbit, Michael; Adams, Nigel; Bannoo, Selina; Leonardi, Antonio; Sandomenico, Annamaria; Raimondo, Domenico; Ruvo, Menotti; Chambery, Angela... Journal: Toxicology reports Issue: Volume 6(2019) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study. (1st March 2021) Authors: Camilleri, Marquita; Cuadrado, Maria; Phillips, Elizabeth; Wilson, William; Jenner, Richard; Pang, Gavin; Kamora, Sumaiya; Streetly, Matthew; Popat, Rakesh; Bygrave, Ceri; Owen, Roger; Cavenagh, James; Chapman, Mike; Sive, Jonathan; Eccersley, Lydia; Sheaff, Michael; Benjamin, Reuben; Ramasamy, K... Journal: British journal of haematology Issue: Volume 193:Number 4(2021) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience. (10th August 2020) Authors: Shah, Vallari; Ko Ko, Thinzar; Zuckerman, Mark; Vidler, Jennifer; Sharif, Sobia; Mehra, Varun; Gandhi, Shreyans; Kuhnl, Andrea; Yallop, Deborah; Avenoso, Daniele; Rice, Carmel; Sanderson, Robin; Sarma, Anita; Marsh, Judith; de Lavallade, Hugues; Krishnamurthy, Pramila; Patten, Piers; Benjamin, Re... Journal: British journal of haematology Issue: Volume 190:Number 5(2020) Page Start: e279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Secondary HLH is uncommon in severe COVID‐19. (10th August 2020) Authors: Wood, Henry; Jones, John R.; Hui, Kit; Mare, Tracey; Pirani, Tasneem; Galloway, James; Metaxa, Victoria; Benjamin, Reuben; Rutherford, Andrew; Cain, Sharon; Kulasekararaj, Austin G. Journal: British journal of haematology Issue: Volume 190:Number 5(2020) Page Start: e283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CAR T cells – the future for cancer therapy. (May 2021) Authors: Benjamin, Reuben Journal: Medicine Issue: Volume 49:Number 5(2021) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗